CN Stock MarketDetailed Quotes

603963 Dali Pharmaceutical

Watchlist

3.57
+0.17+5.00%

Market Closed Nov 8 15:00 CST

784.33MMarket Cap-32162P/E (TTM)

Dali Pharmaceutical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q9)Sep 30, 2024

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

Assets

Current assets

Money funds

1,153.73%207.69M

39.95%139.4M

-28.63%39.68M

-67.62%14.19M

-63.40%16.57M

94.54%99.61M

-15.30%55.6M

-75.73%43.84M

-9.73%45.26M

21.72%51.21M

Transactional financial assets

----

-40.68%80.78M

-15.73%175.73M

-9.81%206.74M

-14.20%206.19M

-42.95%136.17M

-10.89%208.53M

73.08%229.23M

-0.79%240.33M

-0.78%238.68M

Notes receivable and accounts receivable

87.28%7.67M

-69.61%1.75M

-72.44%1.81M

-75.85%1.87M

-35.87%4.09M

-9.32%5.76M

-8.99%6.56M

-3.96%7.73M

-26.20%6.38M

-27.79%6.35M

-Notes receivable

----

-42.70%43.02K

----

18.28%177.44K

-32.11%112.62K

-9.19%75.08K

230.15%96.59K

--150.01K

-44.24%165.89K

-78.14%82.68K

-Accounts receivable

92.57%7.67M

-69.97%1.71M

-72.03%1.81M

-77.72%1.69M

-35.97%3.98M

-9.32%5.68M

-9.97%6.46M

-5.83%7.58M

-25.56%6.22M

-25.52%6.27M

Other receivables (including interest and dividends)

2.74%162.39K

-14.09%156.94K

-28.41%171.87K

1.92%37.43K

-16.94%158.05K

-91.09%182.69K

-88.38%240.07K

-98.10%36.73K

-90.72%190.28K

-12.00%2.05M

-Other receivable

----

-91.09%182.69K

----

-12.00%2.05M

Advance payment

434.87%1.94M

-95.09%328.36K

7.75%410.43K

97.28%547.23K

-35.15%362.56K

1,303.90%6.69M

-90.88%380.91K

593.76%277.39K

-89.80%559.06K

-87.21%476.49K

Inventories

14.03%55.76M

121.42%60.14M

120.44%61.03M

136.27%63.84M

90.85%48.9M

-2.30%27.16M

20.73%27.69M

6.30%27.02M

-58.00%25.62M

-59.30%27.8M

Other current assets

-95.04%87.16K

--289.91

--35.09K

221.42%1.92M

--1.76M

----

--598.23K

----

Total current assets

-1.70%273.3M

2.54%282.57M

-6.73%278.87M

-6.34%289.15M

-12.66%278.03M

-15.61%275.58M

-11.02%298.99M

-11.42%308.73M

-13.86%318.35M

-10.72%326.56M

Non Current assets

Investment real estate

-2.93%60.48M

-2.90%60.93M

-2.88%61.39M

-2.86%61.85M

--62.3M

--62.76M

--63.21M

--63.67M

----

Fixed assets

----

1.11%78.16M

----

46.94%77.3M

----

39.69%82.02M

----

-14.65%52.61M

Constru in process

----

-93.27%5.36M

----

-95.04%3.82M

----

12.18%79.75M

Intangible assets

-3.01%34.16M

-2.76%34.42M

-2.77%34.68M

-2.77%34.95M

-33.21%35.22M

-33.42%35.39M

-33.42%35.67M

-33.43%35.95M

-3.11%52.73M

-3.08%53.16M

Deferred tax assets

-30.37%3.91M

-23.92%4.32M

-26.05%4.94M

-31.43%4.87M

-20.84%5.61M

-17.79%5.68M

-7.28%6.68M

-4.37%7.1M

-12.18%7.09M

-4.19%6.91M

Usufruct assets

-38.68%1.29M

-35.45%1.49M

810.03%1.69M

154.81%1.9M

61.12%2.1M

24.06%2.31M

-92.31%185.96K

-75.00%743.83K

-66.43%1.3M

-58.21%1.86M

Other non current assets

-72.54%171K

-96.07%63.84K

-99.38%9.1K

-95.98%63.1K

--622.8K

--1.63M

--1.48M

--1.57M

----

Total non current assets

-5.34%176.9M

-5.80%179.38M

-4.67%182.47M

-5.22%184.69M

-3.23%186.88M

-1.98%190.42M

-2.71%191.4M

-2.66%194.87M

-2.45%193.12M

-2.49%194.27M

Total assets

-3.16%450.2M

-0.87%461.94M

-5.92%461.34M

-5.91%473.83M

-9.10%464.91M

-10.53%466M

-7.95%490.39M

-8.23%503.6M

-9.88%511.46M

-7.82%520.83M

Liabilities

Current liabilities

Notes payable and accounts payable

24.38%11.46M

6.57%10.3M

-1.48%10.04M

11.99%10.19M

-51.90%9.21M

-49.43%9.66M

-42.92%10.19M

-62.91%9.1M

-35.01%19.15M

-39.41%19.11M

-Accounts payable

24.38%11.46M

6.57%10.3M

-1.48%10.04M

11.99%10.19M

-51.90%9.21M

-49.43%9.66M

-42.92%10.19M

-62.91%9.1M

-35.01%19.15M

-39.41%19.11M

Contract liabilities

2,430.43%26.43M

2,041.85%27.89M

931.49%13.8M

335.01%19.27M

151.85%1.04M

163.56%1.3M

74.14%1.34M

-11.24%4.43M

-84.87%414.67K

-49.33%494.14K

Advance receipts

154.44%993.47K

263.24%1.33M

19.72%643.91K

--169.36K

--390.45K

--366.97K

--537.86K

----

Salaries payable

-85.90%115.02K

-85.28%125.27K

-46.93%836.97K

-60.30%836.97K

5.74%815.63K

26.90%850.99K

19.24%1.58M

38.05%2.11M

-64.49%771.36K

-68.95%670.63K

Taxs payable

59.66%1.28M

62.03%1.44M

-59.43%820.99K

-47.31%2.96M

-81.07%803.56K

-84.15%887.9K

-51.64%2.02M

43.47%5.62M

64.43%4.24M

356.42%5.6M

Other payable (including interest and dividends)

-15.96%27.74M

1.94%29.24M

7.10%35.03M

-1.00%34.67M

6.17%33.01M

-16.05%28.68M

-10.39%32.71M

-8.24%35.02M

-2.32%31.09M

-5.30%34.17M

-Other payable

----

1.94%29.24M

----

-16.05%28.68M

----

-8.24%35.02M

----

-5.30%34.17M

Non current liabilities due within one year

-48.37%8.83M

-30.57%8.82M

-53.40%8.83M

-58.82%8.81M

38.43%17.11M

-38.31%12.71M

10.80%18.94M

25.16%21.4M

-7.74%12.36M

108.89%20.6M

Other current liabilities

563.11%488.55K

4,272.89%1.96M

76.81%43.28K

-43.47%60.6K

36.67%73.68K

-30.15%44.87K

-75.50%24.48K

-83.48%107.19K

-84.80%53.91K

-49.33%64.24K

Total current liabilities

23.83%77.33M

48.82%81.11M

4.01%70.05M

-1.04%76.97M

-8.27%62.45M

-32.46%54.51M

-13.47%67.34M

-14.41%77.78M

-17.51%68.08M

-1.54%80.7M

Current liabilities

Long term loan

-27.67%10.51M

-43.25%10.51M

-41.02%14.02M

-41.05%14.02M

-58.53%14.53M

-36.21%18.52M

-32.17%23.77M

-32.14%23.78M

34.61%35.04M

48.70%29.03M

Deferred tax liabilities

-60.92%192.92K

-34.70%340.67K

41.68%363.84K

22.05%545.02K

-1.17%493.61K

107.55%521.69K

-14.73%256.81K

571.15%446.56K

47.72%499.45K

199.47%251.35K

Long term deferred income

-23.88%280.5K

-22.54%302.5K

-21.33%324.5K

-20.25%346.5K

-19.28%368.5K

-18.39%390.5K

-17.58%412.5K

-16.84%434.5K

-16.16%456.5K

-15.53%478.5K

Lease liabilities

-61.91%493.61K

-58.27%705.16K

--831.6K

--1.3M

--1.69M

----

Total non current liabilities

-31.23%11.48M

-43.85%11.86M

-36.42%15.54M

-36.17%15.74M

-53.63%16.69M

-29.03%21.12M

-37.79%24.44M

-36.78%24.66M

19.16%36M

26.80%29.76M

Total liabilities

12.22%88.81M

22.93%92.97M

-6.75%85.59M

-9.50%92.71M

-23.96%79.14M

-31.54%75.63M

-21.63%91.79M

-21.13%102.44M

-7.69%104.08M

4.77%110.47M

Shareholders equity

Paid-in capital

0.00%219.7M

Capital reserve funds

0.00%117.8M

Surplus reserve funds

0.00%32.67M

Retained profit

-156.27%-8.78M

-105.93%-1.2M

-80.37%5.58M

-64.64%10.96M

-58.08%15.6M

-49.74%20.21M

-37.48%28.44M

-36.36%30.99M

-56.03%37.21M

-55.04%40.2M

Shareholders equity without minority interests

-6.32%361.39M

-5.48%368.97M

-5.73%375.75M

-4.99%381.12M

-5.31%385.77M

-4.87%390.37M

-4.10%398.6M

-4.23%401.16M

-10.43%407.38M

-10.71%410.37M

Total shareholder equity

-6.32%361.39M

-5.48%368.97M

-5.73%375.75M

-4.99%381.12M

-5.31%385.77M

-4.87%390.37M

-4.10%398.6M

-4.23%401.16M

-10.43%407.38M

-10.71%410.37M

Total liabilityies and equity

-3.16%450.2M

-0.87%461.94M

-5.92%461.34M

-5.91%473.83M

-9.10%464.91M

-10.53%466M

-7.95%490.39M

-8.23%503.6M

-9.88%511.46M

-7.82%520.83M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)

	(Q9)Sep 30, 2024	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022
Assets
Current assets
Money funds	1,153.73%207.69M	39.95%139.4M	-28.63%39.68M	-67.62%14.19M	-63.40%16.57M	94.54%99.61M	-15.30%55.6M	-75.73%43.84M	-9.73%45.26M	21.72%51.21M
Transactional financial assets	----	-40.68%80.78M	-15.73%175.73M	-9.81%206.74M	-14.20%206.19M	-42.95%136.17M	-10.89%208.53M	73.08%229.23M	-0.79%240.33M	-0.78%238.68M
Notes receivable and accounts receivable	87.28%7.67M	-69.61%1.75M	-72.44%1.81M	-75.85%1.87M	-35.87%4.09M	-9.32%5.76M	-8.99%6.56M	-3.96%7.73M	-26.20%6.38M	-27.79%6.35M
-Notes receivable	----	-42.70%43.02K	----	18.28%177.44K	-32.11%112.62K	-9.19%75.08K	230.15%96.59K	--150.01K	-44.24%165.89K	-78.14%82.68K
-Accounts receivable	92.57%7.67M	-69.97%1.71M	-72.03%1.81M	-77.72%1.69M	-35.97%3.98M	-9.32%5.68M	-9.97%6.46M	-5.83%7.58M	-25.56%6.22M	-25.52%6.27M
Other receivables (including interest and dividends)	2.74%162.39K	-14.09%156.94K	-28.41%171.87K	1.92%37.43K	-16.94%158.05K	-91.09%182.69K	-88.38%240.07K	-98.10%36.73K	-90.72%190.28K	-12.00%2.05M
-Other receivable	----	----	----	----	----	-91.09%182.69K	----	----	----	-12.00%2.05M
Advance payment	434.87%1.94M	-95.09%328.36K	7.75%410.43K	97.28%547.23K	-35.15%362.56K	1,303.90%6.69M	-90.88%380.91K	593.76%277.39K	-89.80%559.06K	-87.21%476.49K
Inventories	14.03%55.76M	121.42%60.14M	120.44%61.03M	136.27%63.84M	90.85%48.9M	-2.30%27.16M	20.73%27.69M	6.30%27.02M	-58.00%25.62M	-59.30%27.8M
Other current assets	-95.04%87.16K	--289.91	--35.09K	221.42%1.92M	--1.76M	----	----	--598.23K	----	----
Total current assets	-1.70%273.3M	2.54%282.57M	-6.73%278.87M	-6.34%289.15M	-12.66%278.03M	-15.61%275.58M	-11.02%298.99M	-11.42%308.73M	-13.86%318.35M	-10.72%326.56M
Non Current assets
Investment real estate	-2.93%60.48M	-2.90%60.93M	-2.88%61.39M	-2.86%61.85M	--62.3M	--62.76M	--63.21M	--63.67M	----	----
Fixed assets	----	1.11%78.16M	----	----	----	46.94%77.3M	----	39.69%82.02M	----	-14.65%52.61M
Constru in process	----	----	----	----	----	-93.27%5.36M	----	-95.04%3.82M	----	12.18%79.75M
Intangible assets	-3.01%34.16M	-2.76%34.42M	-2.77%34.68M	-2.77%34.95M	-33.21%35.22M	-33.42%35.39M	-33.42%35.67M	-33.43%35.95M	-3.11%52.73M	-3.08%53.16M
Deferred tax assets	-30.37%3.91M	-23.92%4.32M	-26.05%4.94M	-31.43%4.87M	-20.84%5.61M	-17.79%5.68M	-7.28%6.68M	-4.37%7.1M	-12.18%7.09M	-4.19%6.91M
Usufruct assets	-38.68%1.29M	-35.45%1.49M	810.03%1.69M	154.81%1.9M	61.12%2.1M	24.06%2.31M	-92.31%185.96K	-75.00%743.83K	-66.43%1.3M	-58.21%1.86M
Other non current assets	-72.54%171K	-96.07%63.84K	-99.38%9.1K	-95.98%63.1K	--622.8K	--1.63M	--1.48M	--1.57M	----	----
Total non current assets	-5.34%176.9M	-5.80%179.38M	-4.67%182.47M	-5.22%184.69M	-3.23%186.88M	-1.98%190.42M	-2.71%191.4M	-2.66%194.87M	-2.45%193.12M	-2.49%194.27M
Total assets	-3.16%450.2M	-0.87%461.94M	-5.92%461.34M	-5.91%473.83M	-9.10%464.91M	-10.53%466M	-7.95%490.39M	-8.23%503.6M	-9.88%511.46M	-7.82%520.83M
Liabilities
Current liabilities
Notes payable and accounts payable	24.38%11.46M	6.57%10.3M	-1.48%10.04M	11.99%10.19M	-51.90%9.21M	-49.43%9.66M	-42.92%10.19M	-62.91%9.1M	-35.01%19.15M	-39.41%19.11M
-Accounts payable	24.38%11.46M	6.57%10.3M	-1.48%10.04M	11.99%10.19M	-51.90%9.21M	-49.43%9.66M	-42.92%10.19M	-62.91%9.1M	-35.01%19.15M	-39.41%19.11M
Contract liabilities	2,430.43%26.43M	2,041.85%27.89M	931.49%13.8M	335.01%19.27M	151.85%1.04M	163.56%1.3M	74.14%1.34M	-11.24%4.43M	-84.87%414.67K	-49.33%494.14K
Advance receipts	154.44%993.47K	263.24%1.33M	19.72%643.91K	--169.36K	--390.45K	--366.97K	--537.86K	----	----	----
Salaries payable	-85.90%115.02K	-85.28%125.27K	-46.93%836.97K	-60.30%836.97K	5.74%815.63K	26.90%850.99K	19.24%1.58M	38.05%2.11M	-64.49%771.36K	-68.95%670.63K
Taxs payable	59.66%1.28M	62.03%1.44M	-59.43%820.99K	-47.31%2.96M	-81.07%803.56K	-84.15%887.9K	-51.64%2.02M	43.47%5.62M	64.43%4.24M	356.42%5.6M
Other payable (including interest and dividends)	-15.96%27.74M	1.94%29.24M	7.10%35.03M	-1.00%34.67M	6.17%33.01M	-16.05%28.68M	-10.39%32.71M	-8.24%35.02M	-2.32%31.09M	-5.30%34.17M
-Other payable	----	1.94%29.24M	----	----	----	-16.05%28.68M	----	-8.24%35.02M	----	-5.30%34.17M
Non current liabilities due within one year	-48.37%8.83M	-30.57%8.82M	-53.40%8.83M	-58.82%8.81M	38.43%17.11M	-38.31%12.71M	10.80%18.94M	25.16%21.4M	-7.74%12.36M	108.89%20.6M
Other current liabilities	563.11%488.55K	4,272.89%1.96M	76.81%43.28K	-43.47%60.6K	36.67%73.68K	-30.15%44.87K	-75.50%24.48K	-83.48%107.19K	-84.80%53.91K	-49.33%64.24K
Total current liabilities	23.83%77.33M	48.82%81.11M	4.01%70.05M	-1.04%76.97M	-8.27%62.45M	-32.46%54.51M	-13.47%67.34M	-14.41%77.78M	-17.51%68.08M	-1.54%80.7M
Current liabilities
Long term loan	-27.67%10.51M	-43.25%10.51M	-41.02%14.02M	-41.05%14.02M	-58.53%14.53M	-36.21%18.52M	-32.17%23.77M	-32.14%23.78M	34.61%35.04M	48.70%29.03M
Deferred tax liabilities	-60.92%192.92K	-34.70%340.67K	41.68%363.84K	22.05%545.02K	-1.17%493.61K	107.55%521.69K	-14.73%256.81K	571.15%446.56K	47.72%499.45K	199.47%251.35K
Long term deferred income	-23.88%280.5K	-22.54%302.5K	-21.33%324.5K	-20.25%346.5K	-19.28%368.5K	-18.39%390.5K	-17.58%412.5K	-16.84%434.5K	-16.16%456.5K	-15.53%478.5K
Lease liabilities	-61.91%493.61K	-58.27%705.16K	--831.6K	--831.6K	--1.3M	--1.69M	----	----	----	----
Total non current liabilities	-31.23%11.48M	-43.85%11.86M	-36.42%15.54M	-36.17%15.74M	-53.63%16.69M	-29.03%21.12M	-37.79%24.44M	-36.78%24.66M	19.16%36M	26.80%29.76M
Total liabilities	12.22%88.81M	22.93%92.97M	-6.75%85.59M	-9.50%92.71M	-23.96%79.14M	-31.54%75.63M	-21.63%91.79M	-21.13%102.44M	-7.69%104.08M	4.77%110.47M
Shareholders equity
Paid-in capital	0.00%219.7M	0.00%219.7M	0.00%219.7M	0.00%219.7M	0.00%219.7M	0.00%219.7M	0.00%219.7M	0.00%219.7M	0.00%219.7M	0.00%219.7M
Capital reserve funds	0.00%117.8M	0.00%117.8M	0.00%117.8M	0.00%117.8M	0.00%117.8M	0.00%117.8M	0.00%117.8M	0.00%117.8M	0.00%117.8M	0.00%117.8M
Surplus reserve funds	0.00%32.67M	0.00%32.67M	0.00%32.67M	0.00%32.67M	0.00%32.67M	0.00%32.67M	0.00%32.67M	0.00%32.67M	0.00%32.67M	0.00%32.67M
Retained profit	-156.27%-8.78M	-105.93%-1.2M	-80.37%5.58M	-64.64%10.96M	-58.08%15.6M	-49.74%20.21M	-37.48%28.44M	-36.36%30.99M	-56.03%37.21M	-55.04%40.2M
Shareholders equity without minority interests	-6.32%361.39M	-5.48%368.97M	-5.73%375.75M	-4.99%381.12M	-5.31%385.77M	-4.87%390.37M	-4.10%398.6M	-4.23%401.16M	-10.43%407.38M	-10.71%410.37M
Total shareholder equity	-6.32%361.39M	-5.48%368.97M	-5.73%375.75M	-4.99%381.12M	-5.31%385.77M	-4.87%390.37M	-4.10%398.6M	-4.23%401.16M	-10.43%407.38M	-10.71%410.37M
Total liabilityies and equity	-3.16%450.2M	-0.87%461.94M	-5.92%461.34M	-5.91%473.83M	-9.10%464.91M	-10.53%466M	-7.95%490.39M	-8.23%503.6M	-9.88%511.46M	-7.82%520.83M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--
Auditor	--	--	--	Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)	--	--	--	Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

603963 Dali Pharmaceutical

Dali Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target